Cargando…

FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma

Personalized therapy for non-small cell lung cancer (NSCLC), particularly lung adenocarcinoma, has recently been significantly improved by the discovery of various molecular targets. However, this has not been the case for lung squamous cell carcinoma (SCC). In the present study, we identified the f...

Descripción completa

Detalles Bibliográficos
Autores principales:	OKABE, NAOYUKI, EZAKI, JUNJI, YAMAURA, TAKUMI, MUTO, SATOSHI, OSUGI, JUN, TAMURA, HIROSUMI, IMAI, JUN-ICHI, ITO, EMI, YANAGISAWA, YUKA, HONMA, REIKO, GOTOH, MITSUKAZU, WATANABE, SHINYA, WAGURI, SATOSHI, SUZUKI, HIROYUKI
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324586/ https://www.ncbi.nlm.nih.gov/pubmed/25586059 http://dx.doi.org/10.3892/ijo.2015.2817

Ejemplares similares

Family with sequence similarity 83, member B is a predictor of poor prognosis and a potential therapeutic target for lung adenocarcinoma expressing wild-type epidermal growth factor receptor
por: Yamaura, Takumi, et al.
Publicado: (2018)

Successful Management of Crizotinib-Induced Neutropenia in a Patient with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Case Report
por: Osugi, Jun, et al.
Publicado: (2016)

Clinical significance of expanded Foxp3(+) Helios(−) regulatory T cells in patients with non-small cell lung cancer
por: MUTO, SATOSHI, et al.
Publicado: (2015)

Prognostic Impact of Hypoxia-Inducible miRNA-210 in Patients with Lung Adenocarcinoma
por: Osugi, Jun, et al.
Publicado: (2015)

Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer
por: Suzuki, Hiroyuki, et al.
Publicado: (2013)

FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC
por: Richtmann, Sarah, et al.
Publicado: (2019)

FAM83A and FAM83A-AS1 both play oncogenic roles in lung adenocarcinoma
por: Wang, Gaoming, et al.
Publicado: (2021)

LncRNA FAM83A‐AS1 promotes lung adenocarcinoma progression by enhancing the pre‐mRNA stability of FAM83A
por: Wang, Wenyi, et al.
Publicado: (2021)

Evolutionary analysis of FAM83H in vertebrates
por: Huang, Wushuang, et al.
Publicado: (2017)

HER2-positive breast cancer cells expressing elevated FAM83A are sensitive to FAM83A loss
por: Bartel, Courtney A., et al.
Publicado: (2017)

Long noncoding antisense RNA FAM83A‐AS1 promotes lung cancer cell progression by increasing FAM83A
por: Shi, Rongxing, et al.
Publicado: (2019)

FAM83G Is a Novel Inducer of Apoptosis
por: Okada, Junichi, et al.
Publicado: (2020)

Systematic Analysis of Gene Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma with a Case Study of FAM83A and FAM83B
por: Cai, Ling, et al.
Publicado: (2019)

FAM83H is involved in stabilization of β-catenin and progression of osteosarcomas
por: Kim, Kyoung Min, et al.
Publicado: (2019)

FAM83H is involved in the progression of hepatocellular carcinoma and is regulated by MYC
por: Kim, Kyoung Min, et al.
Publicado: (2017)

LncRNA FAM83H-AS1 promotes the malignant progression of pancreatic ductal adenocarcinoma by stabilizing FAM83H mRNA to protect β-catenin from degradation
por: Zhou, Min, et al.
Publicado: (2022)

Casein kinase 1 is recruited to nuclear speckles by FAM83H and SON
por: Kuga, Takahisa, et al.
Publicado: (2016)

The Enamel Phenotype in Homozygous Fam83h Truncation Mice
por: Wang, Shih‐Kai, et al.
Publicado: (2019)

Novel FAM83H mutations in patients with amelogenesis imperfecta
por: Xin, Wang, et al.
Publicado: (2017)

Immune implication of FAM83D gene in hepatocellular carcinoma
por: Meng, Tao, et al.
Publicado: (2021)

Tumor β-catenin expression is associated with immune evasion in non-small cell lung cancer with high tumor mutation burden
por: Muto, Satoshi, et al.
Publicado: (2021)

Long noncoding RNA FAM83A-AS1 facilitates hepatocellular carcinoma progression by binding with NOP58 to enhance the mRNA stability of FAM83A
por: He, Jinyu, et al.
Publicado: (2019)

Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma
por: Liao, Weijia, et al.
Publicado: (2015)

FAM83A is a potential biomarker for breast cancer initiation
por: Marino, Natascia, et al.
Publicado: (2022)

FAM83B is involved in thyroid cancer cell differentiation and migration
por: Cirello, Valentina, et al.
Publicado: (2022)

Overexpression of FAM83A Is Associated with Poor Prognosis of Lung Adenocarcinoma
por: Liu, Xin, et al.
Publicado: (2022)

FAM83A antisense RNA 1 (FAM83A-AS1) silencing impairs cell proliferation and induces autophagy via MET-AMPKɑ signaling in lung adenocarcinoma
por: Zhao, Huijie, et al.
Publicado: (2022)

FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway
por: He, Shanyang, et al.
Publicado: (2021)

Nivolumab-related severe thrombocytopenia in a patient with relapsed lung adenocarcinoma: a case report and review of the literature
por: Hasegawa, Takeo, et al.
Publicado: (2019)

FAM83H and casein kinase I regulate the organization of the keratin cytoskeleton and formation of desmosomes
por: Kuga, Takahisa, et al.
Publicado: (2016)

Missense Mutation in Fam83H Gene in Iranian Patients with Amelogenesis Imperfecta
por: POURHASHEMI, S Jalal, et al.
Publicado: (2014)

Involvement of FAM83 Family Proteins in the Development of Solid Tumors: An Update Review
por: Jiang, Yi, et al.
Publicado: (2023)

An In Vitro System for Evaluating Molecular Targeted Drugs Using Lung Patient-Derived Tumor Organoids
por: Takahashi, Nobuhiko, et al.
Publicado: (2019)

Overexpression of Family with Sequence Similarity 83, Member A (FAM83A) Predicts Poor Clinical Outcomes in Lung Adenocarcinoma
por: Zhang, Jing-Tao, et al.
Publicado: (2019)

Correction to: FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway
por: He, Shanyang, et al.
Publicado: (2021)

Correction: FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway
por: He, Shanyang, et al.
Publicado: (2023)

The efficacy of the Kampo medicine rikkunshito for chemotherapy-induced anorexia (RICH trial): study protocol for a randomized controlled trial
por: Inoue, Takuya, et al.
Publicado: (2017)

A Mutation in the FAM83G Gene in Dogs with Hereditary Footpad Hyperkeratosis (HFH)
por: Drögemüller, Michaela, et al.
Publicado: (2014)

Hyperactivation of EGFR and downstream effector phospholipase D1 by oncogenic FAM83B
por: Cipriano, Rocky, et al.
Publicado: (2013)

Prognostic significance of FAM83D gene expression across human cancer types
por: Walian, Peter J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_a4232r58i23m42al160s032h9b